[子宫内膜癌前哨淋巴结活检——我们的经验]
[Sentinel lymph node biopsy in endometrial cancer--our experience].
作者信息
Jordanov A, Hinkova N, Tzvetkov Ch, Strateva D, Gorchev G, Tomov S, Ivanov I, Popovska S
出版信息
Akush Ginekol (Sofiia). 2014;53(6):25-8.
PURPOSE
The objective of the study was to determine the feasibility of a method described for the first time by Altgassen et al. of labeling sentinel lymph nodes in patients with endometrial cancer using blue dye.
PATIENTS AND METHODS
4 ml of blue dye was administreted in 12 patients with endometrial cancer subserosaly at eigth sites. After 10 min sentinel lymph nodes were harvested.
RESULTS
Detection rate was 91.6%., In only one patient there was no detection of sentinel lymph node and in one patient the sentinel lymph node was marked only in one hemipelvis.
CONCLUSIONS
This method for detection of sentinel lymph nodes in patients with endometrial cancer is promising, fast and easy to implement, but need to conduct additional studies to become part of the standard for the surgical treatment of endometrial cancer
目的
本研究的目的是确定一种由阿尔特加森等人首次描述的、使用蓝色染料标记子宫内膜癌患者前哨淋巴结方法的可行性。
患者与方法
在12例子宫内膜癌患者的浆膜下八个部位注射4毫升蓝色染料。10分钟后采集前哨淋巴结。
结果
检测率为91.6%。仅1例患者未检测到前哨淋巴结，1例患者前哨淋巴结仅在一侧半骨盆被标记。
结论
这种检测子宫内膜癌患者前哨淋巴结的方法前景良好、快速且易于实施，但需要进行更多研究才能成为子宫内膜癌手术治疗标准的一部分。
Zotero 插件